Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barrie J Carter

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Human Gene Therapy|April 11, 2020
My Pathway to Adeno-Associated Virus and Adeno-Associated Virus Gene Therapy: A Personal PerspectiveBarrie J Carter
Human Gene Therapy|May 27, 2005
Adeno-associated virus vectors in clinical trialsBarrie J Carter
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2004
Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspectiveBarrie J Carter
Human Gene Therapy|November 3, 2011
Adeno-associated viral vectors for hereditary emphysema; progressing along the clinical development highwayBarrie J Carter
Human Gene Therapy|May 10, 2022
Suppressing Nonsense for Gene TherapyBarrie J Carter
Human Gene Therapy|May 13, 2017
Authors' Response to Jesse D. Riordan, Hum Gene Ther 2017;28:375-376; DOI: 10.1089/hum.2017.045Arun Srivastava, Barrie J Carter
Human Gene Therapy|November 12, 2016
AAV Infection: Protection from CancerArun Srivastava, Barrie J Carter
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 23, 2003
Nonclinical toxicology in support of licensure of gene therapies. Arlington, VA, USA, March 13-14, 2003Robert M Frederickson, Barrie J Carter, Anne M Pilaro
Antioxidants & Redox Signaling|February 4, 2009
Redox modifier genes and pathways in amyotrophic lateral sclerosisBarrie J Carter, Pervin Anklesaria, Stephanie Choi, et al.
Human Gene Therapy|August 4, 2005
Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapyTerence R Flotte, Erik M Schwiebert, Pamela L Zeitlin, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Human Gene Therapy|April 11, 2020
My Pathway to Adeno-Associated Virus and Adeno-Associated Virus Gene Therapy: A Personal PerspectiveBarrie J Carter
Human Gene Therapy|May 27, 2005
Adeno-associated virus vectors in clinical trialsBarrie J Carter
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2004
Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspectiveBarrie J Carter
Human Gene Therapy|November 3, 2011
Adeno-associated viral vectors for hereditary emphysema; progressing along the clinical development highwayBarrie J Carter
Human Gene Therapy|May 10, 2022
Suppressing Nonsense for Gene TherapyBarrie J Carter
Human Gene Therapy|May 13, 2017
Authors' Response to Jesse D. Riordan, Hum Gene Ther 2017;28:375-376; DOI: 10.1089/hum.2017.045Arun Srivastava, Barrie J Carter
Human Gene Therapy|November 12, 2016
AAV Infection: Protection from CancerArun Srivastava, Barrie J Carter
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 23, 2003
Nonclinical toxicology in support of licensure of gene therapies. Arlington, VA, USA, March 13-14, 2003Robert M Frederickson, Barrie J Carter, Anne M Pilaro
Antioxidants & Redox Signaling|February 4, 2009
Redox modifier genes and pathways in amyotrophic lateral sclerosisBarrie J Carter, Pervin Anklesaria, Stephanie Choi, et al.
Human Gene Therapy|August 4, 2005
Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapyTerence R Flotte, Erik M Schwiebert, Pamela L Zeitlin, et al.
Pageof 2